Mercer Global Advisors
CGON icon

Mercer Global Advisors’s CG Oncology CGON Stock Holding History

Mercer Global Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.9K Buy
+801
New +$52.4K ﹤0.01% 4222

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Global Advisors's CGON Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in CG Oncology (CGON) in Q2 2026: 801 shares worth $56.9K. The stake represents ﹤0.01% of the portfolio and ranks #4222 among its holdings.

212 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Mercer Global Advisors held 801 shares of CG Oncology worth $56.9K as of Q2 2026.
  • CG Oncology was a new Mercer Global Advisors position in Q2 2026.
  • CG Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4222 holding.
  • 212 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.